Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Peripheral × Bleomycin × 1 year × Clear all

Sponsor

Conditions

Hodgkin Disease 9 Lymphoma 4 Neoplasms, Germ Cell and Embryonal 3 Vulvar Neoplasms 1 Teratoma 1 Seminoma 1 Neoplasms, Second Primary 1 Neoplasms 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Hemangioma, Capillary 1 Endodermal Sinus Tumor 1 Desmoid Tumors 1 Carcinoma, Embryonal 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1

Interventions

Cyclophosphamide 11 Prednisone 8 Doxorubicin 8 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 7 Vincristine 6 Azacitidine 5 fludarabine 4 Gemcitabine 4 Etoposide 4 Brentuximab Vedotin 4 romidepsin 3 belinostat 3 Dexamethasone 3 Biopsy 3 10-propargyl-10-deazaaminopterin 3 tazemetostat 2 ruxolitinib 2 pembrolizumab 2 Lenalidomide 2 Bendamustine Hydrochloride 2 venetoclax 1 tislelizumab 1 tipifarnib 1 thymoglobulin 1 sodium-iodide symporter 1 selinexor 1 relatlimab 1 pomalidomide 1 ixazomib 1 ivarmacitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡